Andrasik, M. P., Thiam-Diouf, A., Metch, B., Sharpe, C., & Mulugeta, R. (2018). Substance use patterns of HVTN phase I clinical trial participants: Enrollment, Risk Reduction Counseling and Retention. Vaccine.
Chicago Style CitationAndrasik, Michele Peake, Arame Thiam-Diouf, Barbara Metch, Cameron Sharpe, i Robel Mulugeta. "Substance Use Patterns of HVTN Phase I Clinical Trial Participants: Enrollment, Risk Reduction Counseling and Retention." Vaccine 2018.
Cita MLAAndrasik, Michele Peake, et al. "Substance Use Patterns of HVTN Phase I Clinical Trial Participants: Enrollment, Risk Reduction Counseling and Retention." Vaccine 2018.
Atenció: Aquestes cites poden no estar 100% correctes.